Deutsche Bank raised its price target on Qiagen NV (NYSE: QGEN) to $43.00 (from $42.00) while maintaining a Buy rating.Analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS View Analyst PT Change

Qiagen NV (QGEN) PT Raised to $38 at CitiAugust 2, 2018 6:27 AM Qiagen NV (QGEN) PT Raised to $39.50 at Evercore ISIAugust 1, 2018 12:13 PM Qiagen NV (QGEN) PT Raised to $38 at Morgan StanleyAugust 1, 2018 7:37 AM QIAGEN Creates Collaboration with Japan’s Largest Clinical Laboratory Testing Company, SRL, to Accelerate Launch of Companion DiagnosticsAugust 1, 2018 3:30 AM